Literature DB >> 18525265

Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?

Zacarias J da Silva1, Inês Oliveira, Andreas Andersen, Francisco Dias, Amabélia Rodrigues, Birgitta Holmgren, Sören Andersson, Peter Aaby.   

Abstract

OBJECTIVES: To assess the changes in HIV prevalence and incidence between 1996 and 2006 in urban areas of Bissau.
DESIGN: A cross-sectional survey of 384 randomly selected houses within a community-based follow-up study of HIV-1 and HIV-2.
METHODS: A total of 3242 individuals aged at least 15 years were eligible for inclusion. Participants were interviewed about behavioral and socio-economic factors and had a blood sample drawn. A total of 2548 individuals were tested for antibodies to HIV-1 and HIV-2, of whom 649 had taken part in a similar survey in 1996.
RESULTS: With 0.5% HIV dual reactions included, the overall HIV-1 prevalence was 4.6% (118 out of 2548) and the HIV-2 prevalence was 4.4% (112 out of 2548). The prevalence of HIV-1 increased more for women than men especially in the 25-34-year age group. HIV-2 prevalence decreased below 45 years of age but not for individuals more than 45 years old. The incidence rate between 1996 and 2006 was 0.5 per 100 person-years for HIV-1 and 0.24 per 100 person-years for HIV-2. Compared with a previous period from 1987 to 1996, the incidence of HIV-2 is declining whereas no significant increase in the incidence of HIV-1 was observed.
CONCLUSIONS: The present study shows an increasing prevalence of HIV-1 and a decreasing prevalence of HIV-2 in Guinea-Bissau. HIV is generally a bigger problem for women. Despite the general decline in prevalence, HIV-2 may continue as an infection in older people, especially women.

Entities:  

Mesh:

Year:  2008        PMID: 18525265     DOI: 10.1097/QAD.0b013e328300a33d

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  54 in total

1.  Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.

Authors:  Gülsen Ozkaya Sahin; Birgitta Holmgren; Zacarias da Silva; Jens Nielsen; Salma Nowroozalizadeh; Joakim Esbjörnsson; Fredrik Månsson; Sören Andersson; Hans Norrgren; Peter Aaby; Marianne Jansson; Eva Maria Fenyö
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervals.

Authors:  Victor Raúl Gómez Román; Sanne Skov Jensen; Christian Leo-Hansen; Kristoffer Jarlov Jensen; Christoph Mikkel Janitzek; Candida Medina Rodrigues; Sanne Jespersen; Terese Lea Katzenstein; David da Silva Té; Anders Fomsgaard
Journal:  Clin Vaccine Immunol       Date:  2012-06-06

3.  Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cells.

Authors:  Joseph A Hollenbaugh; Susan M Schader; Raymond F Schinazi; Baek Kim
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

4.  Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali.

Authors:  Josue Togo; Almoustapha Issiaka Maiga; Mariam Sylla; Bourahima Kone; Oumar Dolo; Fatoumata Tata Traore; Samba Adama Sangare; Mamoudou Maiga; Souleymane Diallo; Robert Murphy; Vincent Calvez; Anne-Genevieve Marcelin
Journal:  AIDS Res Hum Retroviruses       Date:  2019-01-22       Impact factor: 2.205

5.  Assessing factors for loss to follow-up of HIV infected patients in Guinea-Bissau.

Authors:  Pernille Bejer Nordentoft; Thomas Engell-Sørensen; Sanne Jespersen; Faustino Gomes Correia; Candida Medina; David da Silva Té; Lars Østergaard; Alex Lund Laursen; Christian Wejse; Bo Langhoff Hønge
Journal:  Infection       Date:  2016-10-14       Impact factor: 3.553

6.  Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.

Authors:  Geoffrey S Gottlieb
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

7.  Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.

Authors:  Maarten F Schim van der Loeff; Natasha Larke; Steve Kaye; Neil Berry; Koya Ariyoshi; Abraham Alabi; Carla van Tienen; Aleksandra Leligdowicz; Ramu Sarge-Njie; Zacharias da Silva; Assan Jaye; Dominique Ricard; Tim Vincent; Sarah Rowland Jones; Peter Aaby; Shabbar Jaffar; Hilton Whittle
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

8.  HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

Authors:  Carla van Tienen; Maarten F Schim van der Loeff; Ingrid Peterson; Matthew Cotten; Birgitta Holmgren; Sören Andersson; Tim Vincent; Ramu Sarge-Njie; Sarah Rowland-Jones; Assan Jaye; Peter Aaby; Hilton Whittle
Journal:  Retrovirology       Date:  2010-06-04       Impact factor: 4.602

9.  Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.

Authors:  Gülşen Özkaya Şahin; Birgitta Holmgren; Enas Sheik-Khalil; Zacarias da Silva; Jens Nielsen; Salma Nowroozalizadeh; Fredrik Månsson; Hans Norrgren; Peter Aaby; Eva Maria Fenyö; Marianne Jansson
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

10.  Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau.

Authors:  Adam Edvin Roth; Christine Stabell Benn; Henrik Ravn; Amabelia Rodrigues; Ida Maria Lisse; Maria Yazdanbakhsh; Hilton Whittle; Peter Aaby
Journal:  BMJ       Date:  2010-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.